Alzheimer Disease Blood Test Approved for Primary Care episode artwork

EPISODE · Dec 5, 2025 · 6 MIN

Alzheimer Disease Blood Test Approved for Primary Care

from JAMA Medical News

Correction: an earlier version of this podcast misstated the phosphorylated tau analyte measured by the Roche blood biomarker test. It is p-tau181, not p-tau217. In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use" and more. Related Content: Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use

NOW PLAYING

Alzheimer Disease Blood Test Approved for Primary Care

0:00 6:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of JAMA Medical News?

This episode is 6 minutes long.

When was this JAMA Medical News episode published?

This episode was published on December 5, 2025.

What is this episode about?

Correction: an earlier version of this podcast misstated the phosphorylated tau analyte measured by the Roche blood biomarker test. It is p-tau181, not p-tau217. In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior...

Can I download this JAMA Medical News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!